The Gist Healthcare Podcast

Gist Healthcare Daily
undefined
Jun 12, 2024 • 9min

Wednesday, June 12, 2024

FDA advisors unanimously recommend approval of Eli Lilly’s Alzheimer’s drug donanemab. The Biden administration proposes a rule to ban medical debt from consumer credit reports. And the U.S. Supreme Court will review a case on Medicare Disproportionate Share Hospital payments. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.
undefined
Jun 11, 2024 • 8min

Tuesday, June 11, 2024

Moderna reports positive results from its COVID-flu combined vaccine late-stage trial. A new Florida law allows doctors to perform c-sections outside of hospitals. And the American Cancer Society aims to enroll 100,000 Black women in an ambitious new cancer study.  That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.
undefined
Jun 10, 2024 • 7min

Monday, June 10, 2024

Kroger Health expands its weight-management program to include GLP-1 treatments. Cases of whooping cough more than double in the U.S. And new research links 200-plus symptoms to long COVID. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.
undefined
Jun 7, 2024 • 8min

Friday, June 7, 2024

Oregon Health & Science University and Legacy Health sign an agreement to merge. A judge rejects an FTC request to block Novant Health’s acquisition of two CHS hospitals. And a group of Senators introduce legislation to overturn the nursing home staffing mandate. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.
undefined
Jun 6, 2024 • 10min

Thursday, June 6, 2024

An FDA advisory panel recommended against using ecstasy as a treatment for PTSD. A Congressional subcommittee weighs reforming the 340B Drug Pricing Program. And a new study reports that drug shortages are more frequent and last longer. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.
undefined
Jun 5, 2024 • 7min

Wednesday, June 5, 2024

SCAN Health Plan wins its Medicare Advantage star ratings lawsuit against CMS. The University of Pittsburgh Medical Center acquires Washington Health System. And a new study highlights racial and ethnic disparities within Medicaid renewal procedural issues. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.
undefined
Jun 4, 2024 • 8min

Tuesday, June 4, 2024

HHS clarifies that Change Healthcare is responsible for data breach notifications – not individual providers. Structure Therapeutics reports that its oral GLP-1 drug led to weight loss in two small studies. And the FDA approves Moderna’s mRNA RSV vaccine for adults over 60. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.
undefined
Jun 3, 2024 • 7min

Monday, June 3, 2024

Novartis sues to block a Maryland law concerning contract pharmacies and the 340B drug pricing program. Hospitals find fault with CMS’ proposed Transforming Episode Accountability Model. And a new study examines the impact of cyberattacks on nearby unattacked hospitals. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.
undefined
May 31, 2024 • 6min

Friday, May 31, 2024

Dollar General and Doc-Go halt their mobile health clinic program. The American Clinical Laboratory Association sues over the FDA’s final rule regulating laboratory-developed tests. And a new report says NIH-funded clinical trials often don't meet their racial & gender diversity enrollment goals. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.
undefined
May 30, 2024 • 7min

Thursday, May 30, 2024

Hospital groups join a multi-sector plea to the FTC to delay a new ban on noncompetes. A new study ties weight-loss drug Wegovy to reduced risk for alcohol use disorder. And drugmaker Eli Lilly says it will spend billions of dollars to expand its GLP-1 production capacity. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app